DSGN vs NTAP · $214.0M cap vs P/E 28, rev $6.24B
Design Therapeutics Inc (DSGN) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported DSGN revenue for 2025-09-30 was $0. Net income was -$53.8M. DSGN currently screens at market cap $214.0M.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
DSGN currently screens at market cap $214.0M. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the DSGN and NTAP stock pages for the full models.
Not investment advice.